Esmolol
Overview
Esmolol is a cardioselective short-acting beta-blocker. Esmolol is administered via IV-infusion and due to ultra short duration of action, is useful for acute control of hypertension or certain supraventricular arrhythmias. Esmolol is also used to control hypertension and tachycardia in perioperative, postoperative or emergency settings.
Primary Characterstics
It is of Synthetic origin and belongs to Benzenepropanoic Acid. . The Molecular Weight of Esmolol is 331.80.
Its pKa is 9.5.
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Albuterol's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 1.5 mg/kg | 1.5 (1.5) | As recommended. | IV | For the management of postintubation tachycardia and hypertension, should be given as a bolus injection (over 30 seconds) 1 to 2 minutes before intubation. |
| 10 mg/ml | 10 (10) | As recommended. | IV | Management of Perioperative Tachycardia and Hypertension: Intubation: Should be administered by a bolus injection over 30 seconds. |
Paedriatic Dosage (20kg)
|
| 25 to 350 mcg/kg/min | 190 (187.5) | As recommended. | IV | |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Albuterol is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Albuterol
Back to top
Previous Drug Generic - Next Drug Generic